Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)

NCT05158140 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

850

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infection

Interventions

BIOLOGICAL: V110
BIOLOGICAL: V114
BIOLOGICAL: mRNA-1273
BIOLOGICAL: Placebo for V110
BIOLOGICAL: Placebo for V114

Sponsor

Merck Sharp & Dohme LLC